Growing evidence suggests that -lipoic acid (LA) has neuroprotective effects in various pathological conditions including brain ischemia and neurodegeneration. While anti-oxidative activity has been thought to play a central role in LA-mediated neuroprotection, the precise mechanism and the effect of LA enantiomers (R-and S-LA) are not fully clarified.
Introduction
Recent studies have demonstrated that enhanced levels of oxidative stress contribute to neuronal death in various pathological conditions including brain ischemia and neurodegeneration (for review, Mehta et al., 2007 , Bossy-Wetzel et al., 2004 . Cerebral ischemia / reperfusion causes rapid production of reactive oxygen species (ROS) which easily overwhelms the anti-oxidative capacity of the brain. In those conditions, ROS can be generated through the activation of NMDA receptors, xanthine oxidation, NADPH oxidation and lipid peroxidation. Several stress-associated signaling cascades such as mitogen-activated protein kinases (MAP kinases) are activated by ROS, and cause neuronal death directly or indirectly via increased production of inflammatory cytokines. In neurodegenerative diseases, in contrast, ROS can be generated through the impairment of intracellular organelles such as mitochondria and endoplasmic reticulum (ER), or inflammatory response derived from glial cells. Accumulation of aggregation-prone proteins such as amyloid  and -synuclein may also contribute to ROS generation (Bossy-Wetzel et al., 2004 , Smith et al., 2005 , Song et al., 2004 . From the view of therapeutic potential, therefore, it is important to find small anti-oxidants which can cross the blood brain barrier (BBB).
Alpha-lipoic acid (LA), or 1,2-dithiolane-3-pentanoic acid is a small sterically hindered disulfide molecule that can dissolve in both water and lipid, and cross the BBB (for review, Shay et al., 2009) . Although LA can exist in both R-and S-enantiomeric forms, naturally found -lipoic acid is a R-isomer that can bind to the -amino moiety of lysine residues by an amide linkage, thus making this isomer essential as a co-factor in the mitochondrial energy metabolism. Chemically synthesized LA, in contrast, is a racemate (a mixture of equal amount of R-and S-LA), and is believed to exert additional beneficial bioactivities when administered exogenously. These include anti-oxidative activities such as chelating metals (Muller et al., 1990) , scavenging reactive oxygen species (ROS) (Matsugo et al, 1995) , recycling / inducing endogenous anti-oxidants (Konishi et al., 1996) , anti-inflammation (Fuchs et al., 1994) , activation of cell signaling (Packer et al., 2011) , and enhancement of glucose uptake (Konrad et al., 2001) . It was also reported that LA had a pro-oxidant activity which leads to cellular adaptation against oxidative stress (Cakatay, 2006) .
In neurological fields, accumulating evidence suggests that LA (racemate or R-LA) has neuroprotective effects in the models of both brain ischemia (Wolz and Krieglstein, 1996, Clark et al., 2001 ) and neurodegeneration such as Alzheimer's disease (AD) (Siedlak et al., 2009 ) and Parkinson's disease (PD) (Karunakaran et al., 2007) . Although the anti-oxidative property has been thought to play a pivotal role in the neuroprotective activity of LA, the precise reaction mechanism and the effect of LA enantiomers, especially that of S-LA, are not fully understood.
We report here that every LA enantiomer (racemate, R-LA or S-LA) most effectively prevented cell death induced by drugs which deplete intracellular glutathione in SH-SY5Y neuroblastoma cells. The underlying mechanism may include Phosphatidylinositol 3-kinases (PI3K) /Akt dependent upregulation of anti-oxidant and /or phase II detoxification genes.
Materials and Methods
Cell cultures. Cells of the human neuroblastoma cell line, SH-SY5Y, were maintained in DMEM containing 15% FBS and 50g/ml of penicillin and 100g/ml of streptomycin. These cells were kept at 37℃ in humidified 5% CO 2 /95% air.
Stress conditions. SH-SY5Y cells were cultured in 24-well plates up to 60-70% confluence, and treated with various stressors for 24-36 h to reduce the viability to 45-60 % of the control cells (non-stressed cells). The stressors used in this study were buthionine sulfoximine (BSO) (1mM: purchased from Wako chemicals, Osaka, Japan) which is an inhibitor of -glutamyl cysteine ligase (-GCL), the rate-limiting enzyme in glutathione synthesis, diethyl maleate (DEM) (150 M: Wako chemicals), which is a chelator of glutathione, hydrogen peroxide (H 2 O 2 ) (22 M: Nacalai Tesque, Kyoto, Japan), MG132 (1M: Nacalai Tesque), which is an inhibitor of proteasome, thapsigargin (Tg) (0.2M: Sigma), which is an inhibitor of sarco/endoplasmic reticulum Ca 2+ -ATPase (SERCA), and tunicamycin (Tm) (1g/ml: Sigma), which is an inhibitor of N-linked glycosylation in the ER. The latter two drugs were used to cause ER stress. -lipoic acid (LA; racemate, R-LA or S-LA) was provided by Dr. Tetsuya Konishi (Niigata University of Pharmacy and Applied Life Sciences). LA was added to the cells in the presence or absence of stressors, and incubated for the indicated times. In some experiments, the cells were treated with LA for 48 h (pre-treatment) prior to the addition of stressors. Chemical inhibitors such as SB202190, a p38 Mitogen-activated protein kinase (MAPK) inhibitor (Sigma), LY294002, a Phosphatidylinositol 3-kinases (PI3K) inhibitor (Sigma), SP600125, a Jun amino-terminal kinase (JNK) inhibitor (Sigma), PD98059, Extracellular signal-regulated kinase (ERK) inhibitor (Sigma), Sn-mesoporphyrin IX (Sn-MP), a heme oxygenase-1 (HO-1) inhibitor (Frontier Scientific Inc., Logan, UT), and dicoumarol, a NAD(P)H:Quinone Oxidoreductase 1 (NQO1) inhibitor (Tokyo Chemical Industry Co., Tokyo, Japan) were added to the cells in the presence or absence of LA and
BSO.
Cell viability and cell death assays. Cell viability and cell death were measured using MTT assay (Nacalai Tesque) and LIVE/DEAD assay (Invitrogen, Carlsbad, CA), respectively, as described previously (Hori et al., 2004) . In the latter experiment, the number of dead cells out of the total cells is shown in the graph.
Measurement of total glutathione and ROS. Total glutathione (GSH/GSSG) content was measured using a Total Glutathione Quantification Kit (DOJINDO, Kumamoto, Japan).
Briefly, SH-SY5Y cells were treated with LA in the presence or absence of 1mM BSO for the indicated times. Cells were then harvested, and lysed in 0.2ml of PBS using a sonicator (Braoson, Danbury, CT). The samples were deproteinized with 20 l of 5% 5-sulfosalicylic acid (SSA: Sigma), and total glutathione was measured following the manufacture's instructions. Intracellular ROS levels were measured using a fluorescent probe, 2', 7'-dichlorodihydrofluorescin diacetate (DCFH-DA: Invitrogen) as described previously (Takano et al., 2007) . SH-SY5Y cells were loaded with 5M DCFH-DA for 20 min and the fluorescence measured by a microscope (Nikon TS100-F ECLIPSE) equipped with a CCD camera (Hamamatsu Photonics, Shizuoka, Japan). Quantification of the fluorescent intensity was performed using Image J (version 1.42, Wayne Rasband, National Institutes of health), and the results presented as a percentage to the control intensity.
Cell lysis, Western blotting and immunostaining. Cells were lysed in RIPA buffer containing 10mM Tris, 1mM EDTA, 150mM NaCl, 1% NP-40, 0.1% SDS, 0.2% sodium deoxycholate and protease inhibitors. Samples were then subjected to Western blotting with anti-p-ERK antibody, anti-ERK antibody, anti-p-JNK antibody, anti-JNK antibody, anti-p-Akt antibody, and anti-Akt antibody (Cell Signaling technology, Beverly, MA). Sites of primary antibody binding were visualized using alkaline phosphatase-conjugated secondary antibodies.
Immunostaining was performed with anti-NF-E2-related factor 2 (Nrf2) antibody (Santa was used as secondary antibody. Nucleus was visualized with DAPI (Sigma).
Quantitative real time RT-PCR (qRT-PCR) . Total RNA was extracted from the SH-SY5Y cells using TRIzol (Invitrogen). RT reactions containing 1 g of total RNA were performed using PrimeScript (Takara, Shiga, Japan). The individual cDNA species were amplified in a reaction mixture containing THUNDERBIRD TM SYBR qPCR ® Mix (TOYOBO CO, LTD, Osaka, Japan) and specific primers for HO-1, NQO1, manganese superoxide dismutase 
Results

Protection of SH-SY5Y cells by LA against glutathione depletion.
To analyze the neuroprotective effects of LA, human neuroblastoma SH-SY5Y cells were treated with different types of stressors such as BSO, H 2 O 2 , MG132, tunicamycin (Tm) and thapsigargin (Tg). After 24-36 h incubation, cell viability and cell death were measured using MTT assay (Fig.1A , C, D, Fig.S1 ) and LIVE/DEAD assay ( Fig.1 B) , respectively.
Each stressor decreased cell viability to 40-60% of control cells ( for 24 h, pre-treatment with LA alone for 48 h followed by BSO treatment for 24 h, and pre-treatment with LA alone for 48 h followed by treatment with LA in the presence of BSO for 24 h (pre-+ co-treatments). In all conditions, LA improved cell viability, but the most effective condition was the combination of pre-and co-treatment of LA (Fig. 1D ). This combined treatment of LA also improved cell viability against the toxicity of H 2 O 2 (Fig. S1 C), as described previously (Zhang et al., 2001 ), but not those of other stressors such as MG132, Tm and Tg (data not shown). As IC 50 of LA against BSO-induced cell death was calculated to be 18.4M in our system, two different concentrations, 20 and 200 M, of LA were used for further experiments.
Effects of LA on the amount of intracellular glutathione.
As it is known that LA increases intracellular glutathione levels (Shay et al., 2009), we hypothesized that LA may protect SH-SY5Y cells against BSO and DEM by modulating glutathione content as previously described (Bharath S et al., 2002) . The levels of total glutathione were measured after LA (racemate) treatment in the presence or absence of BSO.
Treatment of the cells with LA alone enhanced glutathione levels to 150 % of those in control cells both at 16 h and 72 h (48 h+24 h) ( did not restore glutathione levels (Fig. 2 B) , and, importantly, pre-treatment of the cells with LA for 48 h followed by further treatment with LA in the presence of BSO for 24 h only mildly restored the glutathione levels to 15 % of those in control cells (Fig. 2 C) , suggesting that the protective effect of LA in our system may be different from its glutathione-modulating property.
Effects of LA on ROS and oxidative stress response.
As LA can reduce oxidative stress directly by attenuating ROS and indirectly by enhancing the oxidative stress response, a fluorescent dye DCFH-DA was employed to measure the level of ROS. Treatment of SH-SY5Y cells with LA reduced the basal level of ROS to 31 % of that in control cells, while treatment of the cells with BSO enhanced it to 218 % of that in control cells (Fig 3A) . Further analysis revealed that treatment of the cells with LA in the presence of BSO only mildly reduced ROS levels of the cells treated with BSO alone (189 %) (Fig. 3 A) . These results suggested that the direct quenching effect of LA toward ROS was not strong enough to scavenge ROS produced in the reaction system.
The oxidative stress response was next estimated by analyzing expressions of antioxidant genes and phase II detoxification genes at mRNA levels. qRT-PCR analysis revealed that downstream genes of Nrf2 such as HO-1 and NQO1 were strikingly upregulated by LA in the presence or absence of BSO (Fig. 3 B I , II), as described previously (Jia et al., 2008 , Shay et al., 2009 ). Similar tendency was obtained when cells were treated with R-or S-LA (Fig. S2 A) . Immunocytochemical analysis confirmed translocation of Nrf2 from the cytosol to the nucleus upon LA treatment (Fig.S2 C) . In our system, LA also upregulated other anti-oxidant genes such as MnSOD and Trx to lesser degrees ( Fig. S2 B I , II).
Consistent with these results, reduction of anti-oxidant capacity in the cells after BSO treatment was restored by co-treatment with LA (Fig. 3 C) .
To analyze the effect of upregulation of Nrf2-dependent anti-oxidant genes and phase II detoxification enzymes (HO-1 and NQO1) on the LA-mediated cell protection, cells were treated with Sn-mesoporphyrin IX (Sn-MP), an inhibitor of HO-1, or dicoumarol, an inhibitor of NQO1, in the presence or absence of BSO and LA. Dicoumarol (Fig. 3 D) , but not Sn-MP (data not shown), reduced the protective effect of LA at the doses which did not affect cell viability.
Activation of the PI3-kinase/Akt pathway by LA.
As it was reported that LA promoted neuronal cell survival through the activation of Blot analysis revealed that all LA enantiomers activated Akt (Fig. 4 A I, II), but not ERK (Fig. 4 A I) , JNK (Fig. 4 A I ), or p38 (data not shown), at 1-2h after LA treatment.
Consistently, the protective effect of LA against BSO was reduced in the cells treated with the PI3K inhibitor (LY294002), but not with the JNK inhibitor (SP600125), the p38 inhibitor (SB202190) (Fig. 4 B) , or the ERK inhibitor (PD98059) (Fig. S3) .
To elucidate the effect of Akt activation on the upregulation of antioxidant genes and phase II detoxification genes, qRT-PCR was performed using samples derived from cells treated with LY294002 in the presence of LA. LY294002 significantly reduced the levels of expressions of HO-1 (data not shown) and NQO1 (Fig. 4 C) in the presence of LA treatment.
Discussion
Glutathione is the most abundant antioxidant in the brain which serves to detoxify H 2 O 2 by decomposing it into water and oxygen, and keeps the thiol groups of proteins in the reduced state (Mytilineou et al., 2002) . Numerous studies have demonstrated decreased levels of glutathione in pathological conditions including brain ischemia and neurodegenerations.
Postmortem studies have revealed that glutathione levels in the substantia nigra (SN) are decreased with age, and dramatically reduced in the brain of PD patients in concert with the death of dopaminergic neurons in the SN (Perry et al., 1982 , Perry and Yong, 1986 , Riederer et al., 1989 . In experimental animal studies, acute depletion of glutathione caused extensive carbonylation of brain proteins (Bizzozero et al., 2006) and morphological changes of dopaminergic neurons in the nigrostriatal pathway that mimic alterations observed in the brains of aged animals (Andersen et al., 1996) . It is, therefore, critical to find pathways which can improve neuronal survival / activity in the glutathione-depleted condition.
In this paper, we demonstrated that treatment of the cells with LA most effectively prevented cell death induced by drugs which deplete intracellular glutathione in SH-SY5Y cells (Fig. 1, Fig. S1 ). Accumulating evidence has revealed that LA-mediated neuroprotection requires relatively long periods of pre-treatment (hours to days) (Zhang et al., 2001 , Blarath et al., 2002 , Wang et al., 2010 , raising a hypothesis that it may play more critical roles in enhancing the defense system against oxidative stress which includes upregulation of anti-oxidants such as glutathione and HO-1, and phase II enzymes such as NQO1, than directly chelating metals or scavenging reactive oxygen species (ROS) (Shay et al., 2009).
Consistent with this hypothesis, LA-mediated cell protection against BSO was enhanced in the combination of pre-treatment for 48h and co-treatment for 24h in our system (Fig. 1 D) .
H 2 O 2 -induced toxicity was also attenuated in the combination of pre-and co-treatment of LA ( Fig. S1 A II) . Furthermore, expressions of endogenous anti-oxidants such as HO-1 and phase II enzymes such as NQO1 were strikingly upregulated by LA treatment in the presence of BSO (approximately 20-25 fold increase, Fig. 3 B I, II) . The reduction of anti-oxidant capacity upon BSO treatment was also restored by treatment with LA (Fig. 3 C) . Furthermore, an inhibitor of NQO1, but not HO-1, significantly reduced the protective effect of LA against BSO (Fig. 3 D) . In contrast, LA had only mild effects on BSO-mediated glutathione depletion (Fig. 2) or ROS generation (Fig. 3 A) .
How does LA enhance the defense system against oxidative stress? One possibility is activation of signaling pathways such as PI3K/Akt, p38 MAPK, ERK1/2 and JNK (Shay et al., 2009) . Consistent with previous reports (Zhang et al., 2001 , Abdul et al., 2007 , LA activated Akt (Fig. 4 A) , and an inhibitor of PI3K, LY294002, suppressed the effect of LA on NQO1 expression (Fig. 4 C) and cell viability upon BSO treatment (Fig. 4 B) . Another possibility is that LA, as a pro-oxidant, increases both Nrf2-dependent and independent transcriptional activity (Shay et al., 2009) 
. Mild upregulation of MnSOD and Trx expressions
(approximately 3-3.5 fold increase, Fig. S2 B, I, II) upon LA treatment in the presence of BSO may support this, but this is not so likely because the level of ROS was not enhanced either in the cells (Fig. 3 A) or in the media (unpublished observation) after LA treatment.
Regarding LA enantiomers, every LA (racemate, R-LA or S-LA) protected cells against BSO toxicity (Fig. 1 C) and upregulated endogenous anti-oxidants ( Fig. 3 B In conclusion, we demonstrated that all LA enantiomers most effectively prevented cell death induced by drugs which deplete glutathione through several mechanisms including PI3K /Akt-mediated upregulation of phase II enzymes NQO1. 
